Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Reporter nanoparticle that monitors its anticancer efficacy in real time.

Kulkarni A, Rao P, Natarajan S, Goldman A, Sabbisetti VS, Khater Y, Korimerla N, Chandrasekar V, Mashelkar RA, Sengupta S.

Proc Natl Acad Sci U S A. 2016 Apr 12;113(15):E2104-13. doi: 10.1073/pnas.1603455113. Epub 2016 Mar 29.

2.

Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy.

Kulkarni AA, Roy B, Rao PS, Wyant GA, Mahmoud A, Ramachandran M, Sengupta P, Goldman A, Kotamraju VR, Basu S, Mashelkar RA, Ruoslahti E, Dinulescu DM, Sengupta S.

Cancer Res. 2013 Dec 1;73(23):6987-97. doi: 10.1158/0008-5472.CAN-12-4477. Epub 2013 Oct 11.

3.

Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.

Sengupta P, Basu S, Soni S, Pandey A, Roy B, Oh MS, Chin KT, Paraskar AS, Sarangi S, Connor Y, Sabbisetti VS, Kopparam J, Kulkarni A, Muto K, Amarasiriwardena C, Jayawardene I, Lupoli N, Dinulescu DM, Bonventre JV, Mashelkar RA, Sengupta S.

Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11294-9. doi: 10.1073/pnas.1203129109. Epub 2012 Jun 25.

4.

Rapid self-healing hydrogels.

Phadke A, Zhang C, Arman B, Hsu CC, Mashelkar RA, Lele AK, Tauber MJ, Arya G, Varghese S.

Proc Natl Acad Sci U S A. 2012 Mar 20;109(12):4383-8. doi: 10.1073/pnas.1201122109. Epub 2012 Mar 5.

5.

Coupling growth-factor engineering with nanotechnology for therapeutic angiogenesis.

Sinha Roy R, Soni S, Harfouche R, Vasudevan PR, Holmes O, de Jonge H, Rowe A, Paraskar A, Hentschel DM, Chirgadze D, Blundell TL, Gherardi E, Mashelkar RA, Sengupta S.

Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13608-13. doi: 10.1073/pnas.1006007107. Epub 2010 Jul 16.

6.

Harnessing structure-activity relationship to engineer a cisplatin nanoparticle for enhanced antitumor efficacy.

Paraskar AS, Soni S, Chin KT, Chaudhuri P, Muto KW, Berkowitz J, Handlogten MW, Alves NJ, Bilgicer B, Dinulescu DM, Mashelkar RA, Sengupta S.

Proc Natl Acad Sci U S A. 2010 Jul 13;107(28):12435-40. doi: 10.1073/pnas.1007026107. Epub 2010 Jun 23.

7.

Irreverence and Indian science.

Mashelkar RA.

Science. 2010 Apr 30;328(5978):547. doi: 10.1126/science.1191057. No abstract available.

8.

Nanoparticle-mediated targeting of phosphatidylinositol-3-kinase signaling inhibits angiogenesis.

Harfouche R, Basu S, Soni S, Hentschel DM, Mashelkar RA, Sengupta S.

Angiogenesis. 2009;12(4):325-38. doi: 10.1007/s10456-009-9154-4.

PMID:
19685150
9.

Fullerenol-cytotoxic conjugates for cancer chemotherapy.

Chaudhuri P, Paraskar A, Soni S, Mashelkar RA, Sengupta S.

ACS Nano. 2009 Sep 22;3(9):2505-14. doi: 10.1021/nn900318y.

PMID:
19681636
10.

Traditional medicine-inspired approaches to drug discovery: can Ayurveda show the way forward?

Patwardhan B, Mashelkar RA.

Drug Discov Today. 2009 Aug;14(15-16):804-11. doi: 10.1016/j.drudis.2009.05.009. Epub 2009 May 27. Review.

PMID:
19477288
11.

Nanoparticle-mediated targeting of MAPK signaling predisposes tumor to chemotherapy.

Basu S, Harfouche R, Soni S, Chimote G, Mashelkar RA, Sengupta S.

Proc Natl Acad Sci U S A. 2009 May 12;106(19):7957-61. doi: 10.1073/pnas.0902857106. Epub 2009 Apr 21.

12.

Second World Ayurveda Congress (Theme: Ayurveda for the Future)--Inaugural Address: Part III.

Mashelkar RA.

Evid Based Complement Alternat Med. 2008 Dec;5(4):367-9. doi: 10.1093/ecam/nen015. Epub 2008 May 14. No abstract available.

13.

Second World Ayurveda Congress (Theme: Ayurveda for the Future)-Inaugural Address: Part II.

Mashelkar RA.

Evid Based Complement Alternat Med. 2008 Sep;5(3):243-5. doi: 10.1093/ecam/nen014. No abstract available.

14.

Second world ayurveda congress (theme: ayurveda for the future)-inaugural address: part I.

Mashelkar RA.

Evid Based Complement Alternat Med. 2008 Jun;5(2):129-31. doi: 10.1093/ecam/nen013. No abstract available.

15.

Health innovation networks to help developing countries address neglected diseases.

Morel CM, Acharya T, Broun D, Dangi A, Elias C, Ganguly NK, Gardner CA, Gupta RK, Haycock J, Heher AD, Hotez PJ, Kettler HE, Keusch GT, Krattiger AF, Kreutz FT, Lall S, Lee K, Mahoney R, Martinez-Palomo A, Mashelkar RA, Matlin SA, Mzimba M, Oehler J, Ridley RG, Senanayake P, Singer P, Yun M.

Science. 2005 Jul 15;309(5733):401-4.

PMID:
16020723
16.

India's R&D: reaching for the top.

Mashelkar RA.

Science. 2005 Mar 4;307(5714):1415-7. No abstract available.

17.

Morphological changes in degrading PLGA and P(DL)LA microspheres: implications for the design of controlled release systems.

Viswanathan NB, Patil SS, Pandit JK, Lele AK, Kulkarni MG, Mashelkar RA.

J Microencapsul. 2001 Nov-Dec;18(6):783-800.

PMID:
11695641
18.

Thermoprecipitation of lysozyme from egg white using copolymers of N-isopropylacrylamide and acidic monomers.

Vaidya AA, Lele BS, Kulkarni MG, Mashelkar RA.

J Biotechnol. 2001 May 4;87(2):95-107.

PMID:
11278034
19.

Molecularly imprinted adsorbents for positional isomer separation.

Joshi VP, Kulkarni MG, Mashelkar RA.

J Chromatogr A. 1999 Jul 23;849(2):319-30.

PMID:
10457430
20.

Enhancing ligand-protein binding in affinity thermoprecipitation: elucidation of spacer effects

Vaidya AA, Lele BS, Kulkarni MG, Mashelkar RA.

Biotechnol Bioeng. 1999 Aug 20;64(4):418-25.

PMID:
10397880
21.

Preparation of non-porous microspheres with high entrapment efficiency of proteins by a (water-in-oil)-in-oil emulsion technique.

Viswanathan NB, Thomas PA, Pandit JK, Kulkarni MG, Mashelkar RA.

J Control Release. 1999 Mar 8;58(1):9-20.

PMID:
10021485
22.

Lumped-parameter model for haemodialyser with application to simulation of patient-artificial-kidney system.

Ramachandran PA, Mashelkar RA.

Med Biol Eng Comput. 1980 Mar;18(2):179-88. No abstract available.

PMID:
7392683

Supplemental Content

Loading ...
Support Center